Physician profile
Donna J Ko
NPI 1538193024
$889.87
in general payments reported to CMS, 2019-2025
13 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $60.06 · 2022: $24.70 · 2023: $282 · 2024: $124 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $579.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $161.39 | 2019-2023 | |
| Sun Pharmaceutical Industries INC. | $148.45 | 2023-2025 | Winlevi, Odomzo, Blu-U |
| Gilead Sciences, INC. | $115.17 | 2023 | |
| Amgen INC. | $81.22 | 2024-2025 | Otezla |
| Smith+Nephew, INC. | $79.43 | 2024-2025 | Grafix Pl |
| Abbvie INC. | $70.00 | 2023-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $53.21 | 2019-2023 | Arazlo, Jublia |
| Pfizer INC. | $45.39 | 2019-2020 | |
| Biofrontera INC. | $45.10 | 2019-2020 | |
| Almirall LLC | $25.74 | 2023 | Klisyri |
| Allergan, INC. | $24.70 | 2022 | |
| Dusa Pharmaceuticals, INC. | $22.70 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $17.37 | 2023 | Sotyktu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Ko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.